EUVIMEDEUVIMED entdecken
Open Access

Epidemiology of Clostridioides difficile infection at one hospital 10 years after an outbreak of the epidemic C. difficile strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures

Jeffrey T Wieczorkiewicz, Andrew M Skinner iD, Adam Cheknis, Laurica A Petrella, Vanessa W Stevens, Lorinda M Wright, Dale N Gerding, Stuart Johnson iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.00698-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Jeffrey T Wieczorkiewicz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacy, Edward Hines Jr., VA Hospital, Hines, Illinois, USA. Hauptthemen laut MEDLINE: Clostridioides difficile, Anti-Bacterial Agents, Clostridium Infections, Fluoroquinolones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, U.S. Department of Veterans Affairs (VA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In contrast to the epidemiology 10 years earlier at our hospital when the epidemic restriction endonuclease analysis (REA) group strain BI accounted for 72% of Clostridioides difficile isolates recovered from first-episode C. difficile infection (CDI) cases, BI represented 19% of first-episode CDI isolates in 2013–2015. Two additional REA group strains accounted for 31% of isolates (Y, 16%; DH, 12%). High-level resistance to fluoroquinolones and azithromycin was more common among BI isolates than among DH, Y, and non-BI/DH/Y isolates. Multivariable analysis revealed that BI cases were 2.47 times more likely to be associated with fluoroquinolone exposure compared to non-BI cases (95% confidence interval [CI]: 1.12–5.46). In addition, the odds of developing a CDI after third- or fourth-generation cephalosporin exposure was 2.83 times for DH cases than for non-DH cases (95% CI: 1.06–7.54). Fluoroquinolone use in the hospital decreased from 2005 to 2015 from a peak of 113 to a low of 56 antimicrobial days/1,000 patient days. In contrast, cephalosporin use increased from 42 to 81 antimicrobial days/1,000 patient days. These changes correlated with a decrease in geometric mean MIC for ciprofloxacin (61.03 to 42.65 mg/L, P = 0.02) and an increase in geometric mean MIC for ceftriaxone (40.87 to 86.14 mg/L, P < 0.01) among BI isolates. The BI strain remained resistant to fluoroquinolones, but an overall decrease in fluoroquinolone use and increase in cephalosporin use were associated with a decrease in the prevalence of BI, an increased diversity of C. difficile strain types, and the emergence of strains DH and Y.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridioides difficileAnti-Bacterial AgentsClostridium InfectionsFluoroquinolonesMicrobial Sensitivity TestsHumansMaleFemaleAgedPrevalenceMiddle AgedProhibitinsHospitalsDisease OutbreaksAzithromycinCross InfectionAged, 80 and overCephalosporins

Stichwörter der Autor:innen

Clostridium difficileantibiotic resistancemolecular epidemiology

Substanzen

Anti-Bacterial AgentsFluoroquinolonesProhibitinsPHB2 protein, humanAzithromycinCephalosporins

Autor:innen und Institutionen

  • Clinical Pharmacy, Edward Hines Jr., VA Hospital, Hines, Illinois, USA.
  • Department of Pharmacy Practice, Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois, USA.
  • Research and Infectious Diseases Section, George E Wahlen VA Medical Center, Salt Lake City, Utah, USA.
  • Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Research Section, Edward Hines Jr., VA Hospital, Hines, Illinois, USA.
  • Informatics, Decision Enhancement, and Analytic Sciences (IDEAS) Center of Innovation, George E Wahlen VA Medical Center, Salt Lake City, Utah, USA.

ORCID-Profile: Andrew M Skinner, Stuart Johnson

Förderung

  • BLRD VA
  • U.S. Department of Veterans Affairs (VA)

Zitieren

APA

Wieczorkiewicz, J. T., Skinner, A. M., Cheknis, A., Petrella, L. A., Stevens, V. W., Wright, L. M., Gerding, D. N., & Johnson, S. (2024). Epidemiology of Clostridioides difficile infection at one hospital 10 years after an outbreak of the epidemic C. difficile strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00698-24

Vancouver

Wieczorkiewicz JT, Skinner AM, Cheknis A, Petrella LA, Stevens VW, Wright LM, et al. Epidemiology of Clostridioides difficile infection at one hospital 10 years after an outbreak of the epidemic C. difficile strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00698-24

BibTeX
@article{Wieczorkiewicz2024,
  author = {Wieczorkiewicz, Jeffrey T and Skinner, Andrew M and Cheknis, Adam and Petrella, Laurica A and Stevens, Vanessa W and Wright, Lorinda M and Gerding, Dale N and Johnson, Stuart},
  title = {Epidemiology of Clostridioides difficile infection at one hospital 10 years after an outbreak of the epidemic C. difficile strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.00698-24}
}
Kostenlos starten →